<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药融圈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-19T11:29:43+08:00</updated>
  <subtitle>药融圈PHARNEX汇聚数万医药大咖，得到数千家医药创业者鼎力支持，开展日常专题讲座。致力于成为“专业、前沿、权威、严谨”的医药行业资讯平台，以及项目、技术、工厂、融资、股权投资等资源整合平台。欢迎您关注药融圈，共同碰撞“药”的火花!</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>自免大品种：恒瑞IL-17领先，进3期临床已投入1.7亿</title>
    <updated>2020-11-19T00:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/b6YQS53xXHFG3rVRHy3HNg</id>
    <link href="https://mp.weixin.qq.com/s/b6YQS53xXHFG3rVRHy3HNg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>丽珠集团罕见病药物获批，阳光德美助力丹曲林钠研发</title>
    <updated>2020-11-19T00:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/jci4WEkuQVMe3IUExfsOSw</id>
    <link href="https://mp.weixin.qq.com/s/jci4WEkuQVMe3IUExfsOSw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿美乐：精准治疗 让希望同行</title>
    <updated>2020-11-19T00:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/L3vNJtvfe397AUjd8NX-kg</id>
    <link href="https://mp.weixin.qq.com/s/L3vNJtvfe397AUjd8NX-kg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>@医药人，这场石家庄免费制剂技术会议就差你了（内含参会名单）</title>
    <updated>2020-11-19T00:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/JQ_b1c-5zP0zAVnPqZ2bew</id>
    <link href="https://mp.weixin.qq.com/s/JQ_b1c-5zP0zAVnPqZ2bew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新锐|药明系持股近30%，德昇济医药完成2亿美元A轮融资</title>
    <updated>2020-11-19T00:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/BYp04G-Fp-6eYlRDI015iw</id>
    <link href="https://mp.weixin.qq.com/s/BYp04G-Fp-6eYlRDI015iw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】浙江医药创新药稳步推进，维生素盈利向好；鲁抗医药子公司收到盐酸氨溴索注射液《药品注册证书》  ​...</title>
    <updated>2020-11-19T00:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/SfFbwPdUtFh47k7z2KokcQ</id>
    <link href="https://mp.weixin.qq.com/s/SfFbwPdUtFh47k7z2KokcQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>海南海药：与上药所合作共建神经精神疾病药物联合实验室，促进我国神经精神药物创新</title>
    <updated>2020-11-19T00:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/Bm69EGWfjR_XRxy-Yp3Dmg</id>
    <link href="https://mp.weixin.qq.com/s/Bm69EGWfjR_XRxy-Yp3Dmg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>即将终结亚力兄C5单抗独霸时代，补体C3抑制剂上市申请获优先审查</title>
    <updated>2020-11-19T00:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/W92w4N3nGCPCckpFVuluhw</id>
    <link href="https://mp.weixin.qq.com/s/W92w4N3nGCPCckpFVuluhw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>IgA肾病患者福音：布地奈德改良新药即将NDA</title>
    <updated>2020-11-17T18:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/lliDqm6Uc6uYo8BvJ5IQag</id>
    <link href="https://mp.weixin.qq.com/s/lliDqm6Uc6uYo8BvJ5IQag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>海思科：研发投入每年8亿，创新药进入收获期</title>
    <updated>2020-11-17T18:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/XBLTqeDkGAEgo3rkZPE47Q</id>
    <link href="https://mp.weixin.qq.com/s/XBLTqeDkGAEgo3rkZPE47Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新CRO服务&amp;化药制剂两翼齐飞——亚太药业</title>
    <updated>2020-11-17T18:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/raOI0yX3IxE0XVqoSZ_yoQ</id>
    <link href="https://mp.weixin.qq.com/s/raOI0yX3IxE0XVqoSZ_yoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】片仔癀：主动撤回“PZH2109胶囊”临床试验注册申请；恒瑞医药SHR-1314注射液获批临床试验</title>
    <updated>2020-11-17T18:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/4ouZH700tTs0zLPV2ke7BA</id>
    <link href="https://mp.weixin.qq.com/s/4ouZH700tTs0zLPV2ke7BA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>海辰药业：抗肿瘤药物“NMS-03305293 胶囊”获批药物临床试验</title>
    <updated>2020-11-17T18:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/mrhRN1QXmpruj6jyKqZclA</id>
    <link href="https://mp.weixin.qq.com/s/mrhRN1QXmpruj6jyKqZclA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抢免费入场券｜谁将参与石家庄免费制剂技术会议？</title>
    <updated>2020-11-17T18:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/5TngZOK7FtXATfHzzxHWww</id>
    <link href="https://mp.weixin.qq.com/s/5TngZOK7FtXATfHzzxHWww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>10亿市场重磅！注射用泮托拉唑钠集齐3家一致性！另有57个批件待领取！</title>
    <updated>2020-11-17T18:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/wWa5hm-kvb6VkeI7-J87JQ</id>
    <link href="https://mp.weixin.qq.com/s/wWa5hm-kvb6VkeI7-J87JQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>三方围攻NASH，吉列德/诺和诺德NASH组合疗法Ⅱ期临床达到主要终点</title>
    <updated>2020-11-17T18:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/WgKXojx7Y4cM6tBpwusjqQ</id>
    <link href="https://mp.weixin.qq.com/s/WgKXojx7Y4cM6tBpwusjqQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>流感：巴洛沙韦中国优先审评；国内新药在研盘点</title>
    <updated>2020-11-16T18:56:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/v6638XEYM2HnFRF2PH7yfg</id>
    <link href="https://mp.weixin.qq.com/s/v6638XEYM2HnFRF2PH7yfg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>仙琚制药：进击中的原料药制剂一体化甾体龙头</title>
    <updated>2020-11-16T18:56:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/GQ3e2M6BYds_5yvIyoBmhw</id>
    <link href="https://mp.weixin.qq.com/s/GQ3e2M6BYds_5yvIyoBmhw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国新药研发烧钱之最：百济神州拟科创板IPO</title>
    <updated>2020-11-16T18:56:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/XHCVDLa-08uiAlgWoLtboQ</id>
    <link href="https://mp.weixin.qq.com/s/XHCVDLa-08uiAlgWoLtboQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】华东医药与晶泰科技签署合作协议；复旦张江前三季度研发费用同比增长7.41%...</title>
    <updated>2020-11-16T18:56:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/iUcmyPBsiI8hSAFMaF8JSQ</id>
    <link href="https://mp.weixin.qq.com/s/iUcmyPBsiI8hSAFMaF8JSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>